Cogent Biosciences, Inc. (COGT)
32.67
+0.09
(+0.28%)
USD |
NASDAQ |
May 22, 16:00
32.64
-0.02
(-0.08%)
Pre-Market: 20:00
Cogent Biosciences Shareholders Equity (Quarterly) : 607.69M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Syndax Pharmaceuticals, Inc. | 41.62M |
| Vera Therapeutics, Inc. | 499.70M |
| Spyre Therapeutics, Inc. | 670.81M |
| Nuvalent, Inc. | 1.174B |
| Praxis Precision Medicines, Inc. | 1.410B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 903.01M |
| Total Liabilities (Quarterly) | 295.31M |
| Debt to Equity Ratio | 0.3927 |
| Current Ratio | 15.14 |
| Net Debt Paydown Yield | -0.67% |